Review Questions Tamiflu's Effectiveness - myOptumHealth
Links shared publicly online about this topic.
- 1,544total visits
Review Questions Tamiflu's Effectiveness - myOptumHealth
View full resource at myoptumhealth.com
Tags: Flu, Flu Medication, Pneumonia, Drug, Tamiflu
Most Recently Shared on December 9, 2009 at 12:19 am By:
Review Questions Tamiflu's Effectiveness: Finds no proof the drug prevents flu complications such as pneumonia http://bit.ly/74HdE8
Year-End Tech Reflections | Edutopia
edutopia.org — “Blogger Nick Provenzano encourages us to review which tech tools we used during the school year, how effective they were, and whether we should use them again.” View full resource at edutopia.org
Most Recently Shared on May 1, 2012 at 5:27 pm By:
New! Year-End Tech Reflections via @thenerdyteacher http://t.co/KYprR28S #edchat @edtech #edu
Coronary heart disease - PubMed Health
ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on April 5, 2012 at 12:18 pm By:
health screenings.
We take the best of traditional health promotion services and combine
them with technology, clinical expertise, on-site programming, data
input and on-going support services. Dan Keith, Vice President" /> It Starts With Me Health Promotion Programs Health Executive and Active Health Library
Irritable bowel syndrome - PubMed Health
ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on April 4, 2012 at 12:40 pm By:
Crohn's disease - PubMed Health
ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on March 23, 2012 at 11:51 am By:
Ulcerative colitis - PubMed Health
ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on March 23, 2012 at 11:50 am By:
Are Weight-Loss Supplements Effective? Study Says Most Aren't - Shape Magazine
shape.com — “Dr. Melinda Manore, professor of nutrition at Oregon State University, has been doing energy-balance research for 25 years in active and sedentary individuals. The one questions she always gets? “What supplements can I buy for weight loss?” So, like any good researcher she dived into the research, reviewing the evidence surrounding hundreds of weight-loss supplements.” View full resource at shape.com
Most Recently Shared on March 20, 2012 at 6:30 pm By:
Robert T Grant MD Physician, Doctor, Surgeon, and Plastic Surgeon
Are Weight-Loss Supplements Effective? Study Says Most Aren't... http://t.co/pLQqmMGh
FDA staff question benefit of Merck-Ariad drug - Yahoo! News
news.yahoo.com — “From Yahoo! News: WASHINGTON (Reuters) - U.S. drug reviewers questioned whether a sarcoma treatment from Merck & Co Inc and Ariad Pharmaceuticals Inc kept tumors at bay for long enough, given the drug's serious side effects. The drug, called Taltorvic, is meant as a maintenance therapy for people with soft tissue or bone sarcoma who have had four successful rounds of chemotherapy. U.S. Food and Drug Administration staff found the drug stopped cancer from spreading two weeks longer than a placebo” View full resource at news.yahoo.com
Most Recently Shared on March 16, 2012 at 4:19 pm By:
FDA staff question benefit of Merck-Ariad drug: WASHINGTON (Reuters) - U.S. drug reviewers questioned whether a ... http://t.co/ctXdTin7
Sleeping pills linked to death risk - PubMed Health
ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on March 12, 2012 at 9:43 pm By:
Stephen Spates Chiropractor, Acupuncturist, Doctor, and CAM
Sleep aides related to increase in death rate: http://t.co/8p5rMUVU
Ectodermal dysplasia - PubMed Health
ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on March 8, 2012 at 8:41 pm By:
Personal Medicine in Paducah, Kentucky. Dr Hodge was a featured speaker at the Mayo Clinic's Transform Symposium
in '09 and has been named by Brian Dolan of Mobi Heath News as "The
First iPhone Doctor". She is the author of The Personal Pediatrics Primer for the Progressive Parent.
Dr. Hodge's special interests in pediatrics include nutrition,
prevention and the potential for the internet to strengthen physician
patient relationships. Dr. Hodge is a member of the Health care
Information and Management Systems Society (HIMSS), a Fellow of the
Academy of Pediatrics' Quality and Innovation Network, and a founding
member of the Society for Participatory Medicine. Participatory Medicine
is an emerging group of engaged patients and physicians who believe
that mutual trust and understanding as well as use of media, health IT strengthens the physician patient relationship and provides for better care." /> Natalie Hodge, MD, FAAP Pediatrician, Physician, Active Health Library, and Doctor
Ectodermal dysplasia - PubMed Health http://t.co/vHOOEPRH Interesting patient today
Kawasaki disease - PubMed Health
ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on February 21, 2012 at 5:30 pm By:
Vel Ravimohan Doctor, ObGyn Physician, Surgeon, and Physician
Reading about : Kawasaki disease Mucocutaneous lymph node syndrome; Infantile polyarteritis http://t.co/MfpxkjyU
Medical News: New Analysis Challenges Tamiflu Efficacy - in Infectious Disease, Flu & URI from MedPage Today
medpagetoday.com — “A new review of the influenza drug oseltamivir (Tamiflu) has raised questions about both the efficacy of the medication and the commitment of its maker to supply enough data for claims about the drug” View full resource at medpagetoday.com
Most Recently Shared on January 18, 2012 at 12:18 pm By:
Madison Pediatrics
in London, Ohio. Dr. Alexander has long promoted the use of a variety
technologies for advancing healthcare. He is the current director of the
Pediatric Office of the Future for the American Academy of Pediatrics
and also serves on the AAP’s Council on Clinical Information Technology
Executive Committee as well as the Project Advisory Committee for the
Child Health Informatics Center.
An original member of the Ohio Health Information Partnership’s Regional
Extension Center Committee, he was elected to OHIP’s primary Board of
Directors in February, 2011. He further promotes the value of advanced
healthcare technology in his role on the Professional Advisory Council
of ModernMedicine.com and as a regular blogger for HIStalkPractice.com." /> Gregg Alexander, DO Doctor, Pediatrician, Health Executive, Physician, and Active Health Library
New Analysis Challenges Tamiflu Efficacy - in Infectious Disease, Flu & URI from MedPage Today - http://t.co/7MCdPafg from @medpagetoday
Medical News: New Analysis Challenges Tamiflu Efficacy - in Infectious Disease, Flu & URI from MedPage Today
medpagetoday.com — “A new review of the influenza drug oseltamivir (Tamiflu) has raised questions about both the efficacy of the medication and the commitment of its maker to supply enough data for claims about the drug” View full resource at medpagetoday.com
Most Recently Shared on January 18, 2012 at 1:02 am By:
New Analysis Challenges Tamiflu Efficacy (CME/CE): (MedPage Today) -- A new review of the… http://t.co/mtuGqFSw
New Questions Raised About Tamiflu's Effectiveness - NYTimes.com
prescriptions.blogs.nytimes.com — “A new study by the Cochrane Collaboration finds that the Roche drug Tamiflu does not reduce flu complications and transmission as much as previous studies suggested.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on January 18, 2012 at 12:31 am By:
Prescriptions Blog: New Questions Raised About Tamiflu's Effectiveness: A new study by the Cochrane Collaboratio... http://t.co/USIZmcHW
New Questions Raised About Tamiflu's Effectiveness - NYTimes.com
prescriptions.blogs.nytimes.com — “A new study by the Cochrane Collaboration finds that the Roche drug Tamiflu does not reduce flu complications and transmission as much as previous studies suggested.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on January 18, 2012 at 12:06 am By:
New Questions Raised About Tamiflu's Effectiveness http://t.co/uU93MpsJ
Pulmonary hypertension - PubMed Health
ncbi.nlm.nih.gov — “PubMed Health specializes in reviews of clinical effectiveness research, with easy-to-read summaries for consumers as well as full technical reports. Clinical effectiveness research finds answers to the question What works? in medical and health care. PubMed Health is a service provided by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on January 15, 2012 at 10:51 pm By:
Richard Besser Pediatrician, Health Communicator, Physician, and Doctor
What do you need to know? Heres some info: http://t.co/T6YpD3W2 RT @smortie11: @DrRichardBesser Really need info re pulmonary hypertension!
Advertisement
